Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Diagnosis, stratification and monitoring of disease progression in amyotrophic lateral sclerosis currently rely on clinical history and examination. The phenotypic heterogeneity of amyotrophic lateral sclerosis, including extramotor cognitive impairments is now well recognized. Candidate biomarkers have shown variable sensitivity and specificity, and studies have been mainly undertaken only cross-sectionally. Sixty patients with sporadic amyotrophic lateral sclerosis (without a family history of amyotrophic lateral sclerosis or dementia) underwent baseline multimodal magnetic resonance imaging at 3 T. Grey matter pathology was identified through analysis of T1-weighted images using voxel-based morphometry. White matter pathology was assessed using tract-based spatial statistics analysis of indices derived from diffusion tensor imaging. Cross-sectional analyses included group comparison with a group of healthy controls (n = 36) and correlations with clinical features, including regional disability, clinical upper motor neuron signs and cognitive impairment. Patients were offered 6-monthly follow-up MRI, and the last available scan was used for a separate longitudinal analysis (n = 27). In cross-sectional study, the core signature of white matter pathology was confirmed within the corticospinal tract and callosal body, and linked strongly to clinical upper motor neuron burden, but also to limb disability subscore and progression rate. Localized grey matter abnormalities were detected in a topographically appropriate region of the left motor cortex in relation to bulbar disability, and in Broca's area and its homologue in relation to verbal fluency. Longitudinal analysis revealed progressive and widespread changes in the grey matter, notably including the basal ganglia. In contrast there was limited white matter pathology progression, in keeping with a previously unrecognized limited change in individual clinical upper motor neuron scores, despite advancing disability. Although a consistent core white matter pathology was found cross-sectionally, grey matter pathology was dominant longitudinally, and included progression in clinically silent areas such as the basal ganglia, believed to reflect their wider cortical connectivity. Such changes were significant across a range of apparently sporadic patients rather than being a genotype-specific effect. It is also suggested that the upper motor neuron lesion in amyotrophic lateral sclerosis may be relatively constant during the established symptomatic period. These findings have implications for the development of effective diagnostic versus therapeutic monitoring magnetic resonance imaging biomarkers. Amyotrophic lateral sclerosis may be characterized initially by a predominantly white matter tract pathological signature, evolving as a widespread cortical network degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Advances in functional and structural MR image analysis and implementation as FSL
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630 · cited 6×
“As part of the preprocessing pipeline for the FSL-VBM longitudinal analysis, for each of the 27 patients who had both structural images and DTI images for at least two time points (T0 and TMAX), images were bias field-corrected, brain-extracted, and halfway linear registration matrices between T0 and TMAX scans were c…”
MethodInfluentialJenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002) · NeuroImage · doi:10.1006/nimg.2002.1132 · Cited by 11,888
Fast robust automated brain extraction
Smith, S. M. (2002) · Human Brain Mapping · doi:10.1002/hbm.10062 · Cited by 10,496 · cited 2×
“Ethical approval for all procedures was obtained in advance (South Central Oxford Ethics Committee: 08/H0605/85), with written informed consent obtained from all participants.”
MethodZhang, Y., Brady, M., & Smith, S. (2001) · IEEE Transactions on Medical Imaging · doi:10.1109/42.906424 · Cited by 6,982 · cited 2×
“Next, tissue-type segmentation was carried out using FAST4 (Zhang et al., 2001).”
MethodA global optimisation method for robust affine registration of brain images
Jenkinson, M., & Smith, S. (2001) · Medical Image Analysis · doi:10.1016/s1361-8415(01)00036-6 · Cited by 6,872 · cited 3×
“The resulting grey matter partial volume images were then aligned into MNI space using the affine registration tool FLIRT, followed by non-linear registration using FNIRT.”
MethodTract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., Watkins, K. E., Ciccarelli, O., Cader, M. Z., Matthews, P. M., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.02.024 · Cited by 6,478 · cited 1×
“Next, the mean fractional anisotropy image was created and thinned to create a mean fractional anisotropy skeleton (Smith et al., 2006), which represents the centres of all tracts common to the group.”
MethodEl Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433 · cited 2×
“Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis”
BackgroundSMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250 · cited 2×
“Subsequently, using FNIRT, the bias field corrected T0 and TMAX images were non-linearly registered to their average image in halfway space that was obtained after linear registration.”
MethodInfluentialA Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0786 · Cited by 4,561
Cited by
A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis
Müller, H.-P., Turner, M. R., Grosskreutz, J., Abrahams, S., Bede, P., Govind, V., Prudlo, J., Ludolph, A. C., Filippi, M., & Kassubek, J. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311952 · Cited by 175
“sensitive cerebral pathology found in cross-sectional MRI studies in ALS patients has been in the white matter tracts,[14] in contrast to the characteristic hippocampal atrophy that largely defines Alzheimer’s Disease.”
BackgroundSelf-citationCerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
Thompson, A. G., Gray, E., Thézénas, M., Charles, P. D., Evetts, S., Hu, M. T., Talbot, K., Fischer, R., Kessler, B. M., & Turner, M. R. (2018) · Annals of Neurology · doi:10.1002/ana.25143 · Cited by 130
Self-citationLongitudinal imaging in C9ORF72 mutation carriers: relationship to phenotype
Floeter, M. K., Bageac, D., Danielian, L. E., Braun, L. E., Traynor, B. J., & Kwan, J. Y. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.10.014 · Cited by 75
“Our finding of ventricular enlargement in the symptomatic C9+ group over 6 months is consistent with previous longitudinal studies in sporadic ALS that detected grey matter loss over a 6-month (Menke et al., 2014) or 1-year (Kwan et al.”
11 C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
Tondo, G., Iaccarino, L., Cerami, C., Vanoli, G. E., Presotto, L., Masiello, V., Coliva, A., Salvi, F., Bartolomei, I., Mosca, L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51112 · Cited by 56
“In addition, voxelbased morphometry studies confirmed a widespread grey matter atrophy in sALS patients, peaking in the motor cortices and extending to the basal ganglia, thalamus, and cerebellum.(71,72) The brainstem involvement was also reported in a large population of sALS and primary lateral sclerosis patients, d…”
BackgroundOccasional essay: upper motor neuron syndrome in amyotrophic lateral sclerosis
Swash, M., Burke, D., Turner, M. R., Grosskreutz, J., Leigh, P. N., deCarvalho, M., & Kiernan, M. C. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321938 · Cited by 35
Self-citationKassubek, J., Müller, H.-P., Del Tredici, K., Hornberger, M., Schroeter, M. L., Müller, K., Anderl-Straub, S., Uttner, I., Grossman, M., Braak, H., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00047 · Cited by 23
Metadata
- Authors
- Menke, R. A. L., Körner, S., Filippini, N., Douaud, G., Knight, S., Talbot, K., & Turner, M. R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-20
- Volume
- 137
- Issue
- 9
- Pages
- 2546-2555
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2082468728
- Cited by
- 189
- References
- 70
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.